an update on kidney diseases and cancer

Lots of people are struggling with kidney disease or cancer around the world. chronic kidney disease (ckd) and renal cell carcinoma (rcc) are associated directionally and share risk factors. because of the role of kidneys in detoxification, studying the relationship between cancer chemotherapy and kidney disorders is significant. this investigation fills the current gap between cancer occurrence and kidney problems. ckd can induce rcc through a cystic disorder or oxidative stress. rcc also promotes ckd due to the tumor interactions, physical removal of kidney mass, and perioperative acute renal disease. kidney failure also leads to renal cancer-specific pathways. for example, renal progenitors are converted to tumor-initiating cells through hif, notch, mtor, and hippo pathways. furthermore, progress in cancer treatment during recent years has increased the overall survival of patients with advanced malignancies faced with early and late adverse effects from therapeutics. there are conflicting findings about the dosing of typical chemotherapeutics because of loss of kidney function. recommended doses are usually according to expert opinion, not scientific evidence. this investigation has evaluated issues in cancer patients with kidney problems that can help patients by informing physicians about gfr loss and its effect on chemotherapy.keywords: kidney diseases, cancer, chemotherapy, ckd, aki